NCT07558954Not yet recruiting
Application Construction and Effect Evaluation of Family-empowered Pulmonary Rehabilitation in School-age Children With Asthma
Source: ClinicalTrials.gov · Last updated 30 Apr 2026
Brief summary (registry, in English)
Study Purpose: To develop a pulmonary rehabilitation intervention program suitable for school-age children with asthma, and to evaluate its effectiveness in improving asthma control in children through a prospective randomized controlled trial. Study Methods: This is a single-center, prospective, randomized, open-label, parallel-controlled trial. Eligible subjects who meet all inclusion criteria and none of the exclusion criteria, together with their families, will be randomly assigned in a 1:1 ratio to either the intervention group (family-empowered pulmonary rehabilitation intervention) or the control group (conventional pulmonary rehabilitation care) after signing the informed consent form. Both groups will receive a 12-week core intervention period, with follow-up assessments conducted at baseline, end of intervention (12 weeks), and at 24 and 48 weeks after intervention.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 92 (estimated)
- First submitted
- 27 Feb 2026
- Start date
- 1 May 2026
- Primary completion date
- 31 Oct 2027
- Lead sponsor
- The Children's Hospital of Zhejiang University School of Medicine
- Diseases
- Asthma
- NCT number
- NCT07558954
What you commit to
- Study type: Interventional
- Planned participants: 92
- From 1 May 2026 to the primary completion date, 31 Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of other severe chronic diseases (e.g., congenital heart disease, neuromuscular disease, immunodeficiency disease, etc.).
- Children with mental or psychological disorders who cannot cooperate.
- Other conditions judged by the investigator to be unsuitable for participation in this study.
Other
- Children in acute asthma exacerbation.
Who the study is looking for
- School-aged children aged 6 to 12 years.
- Meet the diagnostic criteria for asthma according to the Guidelines for the Diagnosis and Prevention of Bronchial Asthma in Children (2025 Edition).
- Received regular inhaled asthma medications for at least 3 months, with moderate or better medication adherence (score ≥6 on the Morisky Medication Adherence Scale).
- Pulmonary function test shows obstructive ventilatory dysfunction or small airway dysfunction.
- The primary caregiver has good communication and literacy skills, can use smartphone applications (e.g., WeChat) proficiently, and is willing to participate in the study.
- Written informed consent has been obtained from the participant and their legal guardian.
Age in the registry: 6 years to 12 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.